Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn

Table of Contents

January 01, 1995; Volume 272,Issue 1
  • You have access
    Bidirectional effects of endogenous opioid peptides on endothelin release rates in porcine aortic endothelial cell culture: mediation by delta opioid receptor and opioid receptor antagonist-insensitive mechanisms.
    R M Arendt, M Schmoeckel, U Wilbert-Lampen, A Plasse, L Heucke and K Werdan
    Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 1-7;
  • You have access
    Subtype-specific changes in ligand binding properties after solubilization of muscarinic receptors from baculovirus-infected Sf9 insect cell membranes.
    A Rinken
    Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 8-14;
  • You have access
    Up-regulation of brain PGE2 and PGF2 alpha receptors and receptor-coupled second messengers by cyclooxygenase inhibition in newborn pigs.
    D Y Li, D R Varma and S Chemtob
    Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 15-19;
  • You have access
    Nonpeptide glycoprotein IIb/IIIa inhibitors. 5. Antithrombotic effects of MK-0383.
    J J Lynch, J J Cook, G R Sitko, M A Holahan, D R Ramjit, M J Mellott, M T Stranieri, I I Stabilito, G Zhang and R J Lynch
    Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 20-32;
  • You have access
    Vasorelaxant and second messenger effects of maxadilan.
    S A Grevelink, J Osborne, J Loscalzo and E A Lerner
    Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 33-37;
  • You have access
    Cyclothiazide acts at a site on the alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor complex that does not recognize competitive or noncompetitive AMPA receptor antagonists.
    M A Desai, J P Burnett, P L Ornstein and D D Schoepp
    Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 38-43;
  • You have access
    Dilator prostanoid-induced cyclic AMP formation and release by cerebral microvascular smooth muscle cells: inhibition by indomethacin.
    H Parfenova, P Hsu and C W Leffler
    Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 44-52;
  • You have access
    The coagulation system, but not circulating fibrinogen, contributes to liver injury in rats exposed to lipopolysaccharide from gram-negative bacteria.
    J A Hewett and R A Roth
    Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 53-62;
  • You have access
    Transport of oral cephalosporins by the H+/dipeptide cotransporter and distribution of the transport activity in isolated rabbit intestinal epithelial cells.
    Y Tomita, M Takano, M Yasuhara, R Hori and K Inui
    Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 63-69;
  • You have access
    Activation of endogenous thromboxane A2 biosynthesis mediates presynaptic inhibition by endothelin-3 of dog stellate ganglionic transmission.
    K Kushiku, H Ohjimi, H Yamada, T Kuwahara and T Furukawa
    Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 70-76;
  • You have access
    Neurotransmitter-specific profiles of inositol phosphates in rat brain cortex: relation to the mode of receptor activation of phosphoinositide phospholipase C.
    E Sarri, F Picatoste and E Claro
    Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 77-84;
  • You have access
    Specific effects of zatebradine on sinus node function: suppression of automaticity, prolongation of sinoatrial conduction and pacemaker shift in the denervated canine heart.
    J M Kalman, A M Tonkin and J M Power
    Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 85-93;
  • You have access
    Effects of probenecid and cimetidine on the renal excretion of 3'-azido-3'-deoxythymidine in rats.
    T Aiba, Y Sakurai, S Tsukada and T Koizumi
    Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 94-99;
  • You have access
    Drug discrimination analysis of midazolam under a three-lever procedure: I. Dose-dependent differences in generalization and antagonism.
    C A Sannerud and N A Ator
    Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 100-111;
  • You have access
    Effects on ethanol withdrawal hyperexcitability of chronic treatment with a competitive N-methyl-D-aspartate receptor antagonist.
    T L Ripley and H J Little
    Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 112-118;
  • You have access
    Quantitation of the renal clearance of interleukin-2 using nephrectomized and ureter-ligated rats.
    J A Gibbons, Z P Luo, E R Hannon, R A Braeckman and J D Young
    Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 119-125;
  • You have access
    Differential effects of L-NAME on blood pressure and heart rate responses to acetylcholine and bradykinin in cynomolgus primates.
    S M Weldon, R J Winquist and J B Madwed
    Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 126-133;
  • You have access
    Cloning and pharmacological characterization of human alpha-1 adrenergic receptors: sequence corrections and direct comparison with other species homologues.
    D A Schwinn, G I Johnston, S O Page, M J Mosley, K H Wilson, N P Worman, S Campbell, M D Fidock, L M Furness and D J Parry-Smith
    Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 134-142;
  • You have access
    5-Hydroxytryptamine2B receptor signaling in rat stomach fundus: role of voltage-dependent calcium channels, intracellular calcium release and protein kinase C.
    D A Cox and M L Cohen
    Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 143-150;
  • You have access
    The effect of cigarette smoking on adrenal cortical hormones.
    J A Baron, R J Comi, V Cryns, T Brinck-Johnsen and N G Mercer
    Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 151-155;
  • You have access
    The effect of acyl CoA: cholesterol acyltransferase inhibition on the uptake, esterification and secretion of cholesterol by the hamster small intestine.
    R E Burrier, A A Smith, D G McGregor, L M Hoos, D L Zilli and H R Davis
    Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 156-163;
  • You have access
    Ontogeny of nigrostriatal dopamine neuron autoreceptors: iontophoretic studies.
    L Wang and D K Pitts
    Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 164-176;
  • You have access
    Effects of duloxetine, a new serotonin and norepinephrine uptake inhibitor, on extracellular monoamine levels in rat frontal cortex.
    T Kihara and M Ikeda
    Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 177-183;
  • You have access
    Effects of flecainide, quinidine, and 4-aminopyridine on transient outward and ultrarapid delayed rectifier currents in human atrial myocytes.
    Z Wang, B Fermini and S Nattel
    Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 184-196;
  • You have access
    High-performance liquid chromatography separation of hydroxylated estradiol metabolites: formation of estradiol metabolites by liver microsomes from male and female rats.
    L A Suchar, R L Chang, R T Rosen, J Lech and A H Conney
    Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 197-206;
  • You have access
    Reversal of nerve ligation-induced allodynia by spinal alpha-2 adrenoceptor agonists.
    T L Yaksh, J W Pogrel, Y W Lee and S R Chaplan
    Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 207-214;
  • You have access
    3-Isobutyl-1-methylxanthine increases alpha-1-adrenergic receptor sensitivity and density in DDT1-MF2 smooth muscle cells.
    J B Schachter and B B Wolfe
    Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 215-223;
  • You have access
    In vivo inhibition of endotoxin-induced pro-inflammatory cytokines production by the sigma ligand SR 31747.
    J M Derocq, B Bourrié, M Ségui, G Le Fur and P Casellas
    Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 224-230;
  • You have access
    Discriminative stimulus, self-reported and cardiovascular effects of orally administered cocaine in humans.
    A H Oliveto, M I Rosen, S W Woods and T R Kosten
    Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 231-241;
  • You have access
    Carrier-mediated transport mechanism of foscarnet (trisodium phosphonoformate hexahydrate) in rat intestinal tissue.
    P W Swaan and J J Tukker
    Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 242-247;
  • You have access
    Renal adaptation to altered dietary sulfate in rats.
    L J Benincosa, K Sagawa and M E Morris
    Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 248-255;
  • You have access
    FR121196, a potential antidementia drug, ameliorates the impaired memory of rat in the Morris water maze.
    M Yamazaki, N Matsuoka, N Maeda, K Kuratani, Y Ohkubo and I Yamaguchi
    Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 256-263;
  • You have access
    Sodium 2,3-dimercaptopropane-1-sulfonate challenge test for mercury in humans: II. Urinary mercury, porphyrins and neurobehavioral changes of dental workers in Monterrey, Mexico.
    D Gonzalez-Ramirez, R M Maiorino, M Zuniga-Charles, Z Xu, K M Hurlbut, P Junco-Munoz, M M Aposhian, R C Dart, J H Diaz Gama and D Echeverria
    Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 264-274;
  • You have access
    Dose- and duration-dependent tolerance to rotational effects of apomorphine in a rat model of Parkinsonism.
    S Gancher, J Crabbe, A Garland, E Lea and W Woodward
    Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 275-281;
  • You have access
    Peripheral beta adrenergic blockade modifies airpuff startle-induced heart rate responses.
    O A Abdeen, B K Taylor, K L Youngblood and M P Printz
    Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 282-289;
  • You have access
    Calcium modulation of morphine analgesia: role of calcium channels and intracellular pool calcium.
    F L Smith and D L Stevens
    Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 290-299;
  • You have access
    7-Chloro-3-methyl-3-4-dihydro-2H-1,2,4 benzothiadiazine S,S-dioxide (IDRA 21): a benzothiadiazine derivative that enhances cognition by attenuating DL-alpha-amino-2,3-dihydro-5-methyl-3-oxo-4-isoxazolepropanoic acid (AMPA) receptor desensitization.
    I Zivkovic, D M Thompson, M Bertolino, D Uzunov, M DiBella, E Costa and A Guidotti
    Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 300-309;
  • You have access
    Modulation of cannabinoid-induced antinociception after intracerebroventricular versus intrathecal administration to mice: possible mechanisms for interaction with morphine.
    S P Welch, C Thomas and G S Patrick
    Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 310-321;
  • You have access
    Properties of delta opioid receptor in neuroblastoma NS20Y: receptor activation and neuroblastoma proliferation.
    P Y Law and C Bergsbaken
    Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 322-332;
  • You have access
    Systemically administered cocaine selectively enhances long-latency responses of rat barrel field cortical neurons to vibrissae stimulation.
    I Bekavac and B D Waterhouse
    Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 333-342;
  • You have access
    Hypotensive and natriuretic effects of RB 105, a new dual inhibitor of angiotensin converting enzyme and neutral endopeptidase in hypertensive rats.
    W Gonzalez Vera, M C Fournié-Zaluski, I Pham, I Laboulandine, B P Roques and J B Michel
    Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 343-351;
  • You have access
    Relationship between pharmacokinetics and the analgesic effect of ketorolac in the rat.
    V Granados-Soto, F J López-Muñoz, E Hong and F J Flores-Murrieta
    Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 352-356;
  • You have access
    Nitric oxide and prostaglandins in regulation of acid secretory response in rat stomach following injury.
    K Takeuchi, K Takehara, T Kaneko and S Okabe
    Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 357-363;
  • You have access
    Effect of alpha adrenergic agonist on the rabbit ear artery contraction to serotonin: enhanced response mediated by serotonergic1-like receptors.
    H Movahedi, H T Le, H M Spanggord and R E Purdy
    Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 364-370;
  • You have access
    Interaction of galanin fragments with galanin receptors on isolated smooth muscle cells from guinea pig stomach: identification of a novel galanin receptor subtype.
    Z F Gu, T K Pradhan, D H Coy and R T Jensen
    Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 371-378;
  • You have access
    Isoproterenol causes hyperpolarization through opening of ATP-sensitive potassium channels in vascular smooth muscle of the canine saphenous vein.
    M Nakashima and P M Vanhoutte
    Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 379-384;
  • You have access
    Distribution of VIP binding sites in opossum internal anal sphincter circular smooth muscle.
    S Chakder and S Rattan
    Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 385-391;
  • You have access
    Prolonged microvascular vasodilation induced by leukotriene B4 in human skin is cyclooxygenase independent.
    S W Larkin, L Fraser, H J Showell, T J Williams and J B Warren
    Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 392-398;
  • You have access
    5-Aminosalicylic acid abrogates T-cell proliferation by blocking interleukin-2 production in peripheral blood mononuclear cells.
    C Stevens, M Lipman, S Fabry, M Moscovitch-Lopatin, W Almawi, S Keresztes, M A Peppercorn and T B Strom
    Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 399-406;
  • You have access
    Role of metabolism by esterase and cytochrome P-450 in cocaine-induced suppression of the antibody response.
    T C Jeong, S D Jordan, R A Matulka, E D Stanulis, E J Kaminski and M P Holsapple
    Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 407-416;
  • You have access
    BPC-15 reduces trinitrobenzene sulfonic acid-induced colonic damage in rats.
    M Veljaca, C A Lesch, R Pllana, B Sanchez, K Chan and A Guglietta
    Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 417-422;
  • You have access
    Characterization of the cloned human mu opioid receptor.
    K Raynor, H Kong, A Mestek, L S Bye, M Tian, J Liu, L Yu and T Reisine
    Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 423-428;
  • You have access
    4-(2'-Methoxy-phenyl)-1-[2'-(n-2"-pyridinyl)-p-iodobenzamido]-ethyl- piperazine ([125I]p-MPPI) as a new selective radioligand of serotonin-1A sites in rat brain: in vitro binding and autoradiographic studies.
    M P Kung, D Frederick, M Mu, Z P Zhuang and H F Kung
    Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 429-437;
  • You have access
    gamma-Aminobutyric acid gating of Cl- channels in recombinant GABAA receptors.
    I Ducić, H J Caruncho, W J Zhu, S Vicini and E Costa
    Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 438-445;
  • You have access
    Is the "atypical" beta-receptor in the rat stomach fundus the rat beta 3 receptor?
    M L Cohen, J G Granneman, A Chaudhry, K W Schenck, D J Cushing and A D Palkowitz
    Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 446-451;
  • You have access
    Lipopolysaccharide-induced hypotension and vascular hyporeactivity in the rat: tissue analysis of nitric oxide synthase mRNA and protein expression in the presence and absence of dexamethasone, NG-monomethyl-L-arginine or indomethacin.
    G J Hom, S K Grant, G Wolfe, T J Bach, D E MacIntyre and N I Hutchinson
    Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 452-459;
  • You have access
    The immunosuppressant leflunomide inhibits lymphocyte progression through cell cycle by a novel mechanism.
    H M Cherwinski, D McCarley, R Schatzman, B Devens and J T Ransom
    Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 460-468;
  • You have access
    Acetic acid-induced colitis in normal and essential fatty acid deficient rats.
    N Mascolo, A A Izzo, G Autore, F M Maiello, G Di Carlo and F Capasso
    Journal of Pharmacology and Experimental Therapeutics January 1995, 272 (1) 469-475;
Back to top
PreviousNext

In this issue

Journal of Pharmacology and Experimental Therapeutics
Vol. 272, Issue 1
1 Jan 1995
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Read
Loading
  • Potential Clinical Uses of CBG
  • Ocular Drug Delivery: Past, Present, and Future
  • Rho GTPase–Pathway Inhibitor Reduces Markers of Fibrosis
  • Nose-to-Brain Delivery
  • Stem Cells Therapies in AD
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics